No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects

INTRODUCTION: Semaglutide is a glucagon-like peptide-1 (GLP-1) analog approved for the once-weekly treatment of type 2 diabetes. The objective of this 16-week, double-blind, single-center thorough QT study was to confirm that semaglutide treatment does not prolong cardiac repolarization versus place...

Descripción completa

Detalles Bibliográficos
Autores principales: Demmel, Valentin, Sandberg-Schaal, Anne, Jacobsen, Jacob B., Golor, Georg, Pettersson, Jonas, Flint, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064589/
https://www.ncbi.nlm.nih.gov/pubmed/29799100
http://dx.doi.org/10.1007/s13300-018-0442-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064589/
https://www.ncbi.nlm.nih.gov/pubmed/29799100
http://dx.doi.org/10.1007/s13300-018-0442-0

Ejemplares similares